Blue Trust Inc’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Blue Trust Inc’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-621	Closed	-$42K	–	2751
2022 Q4	$42K	Hold	621	–	–	﹤0.01%	996
2022 Q3	$20K	Hold	621	–	–	﹤0.01%	1102
2022 Q2	$22K	Buy	+621	New	+$18.2K	﹤0.01%	929

Other funds holding GBT

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Blue Trust Inc's GBT Position: Q1 2023 in Review

Blue Trust Inc sold out of Global Blood Therapeutics, Inc. (GBT) in Q1 2023, closing a stake of 621 shares — an estimated $42K sold.

Blue Trust Inc first reported a position in GBT in Q2 2022 and held it in 3 quarters. The position peaked at $42K in Q4 2022. 1 fund tracked by Wall St. Rank holds GBT as of Q1 2023.

Blue Trust Inc reported no remaining Global Blood Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
Blue Trust Inc sold 621 Global Blood Therapeutics, Inc. shares in Q1 2023, an estimated $42K.
Blue Trust Inc first reported a position in Global Blood Therapeutics, Inc. in Q2 2022 and held it in 3 quarters.
Blue Trust Inc's Global Blood Therapeutics, Inc. position peaked at $42K in Q4 2022.
1 fund tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2023.

Based on Blue Trust Inc's 13F filing for Q1 2023, filed 17 Apr 2023.